VETO-CELLS OBTAINED FROM MEMORY T-CELLS Russian patent published in 2022 - IPC C12N5/783 A61K35/17 A61K39/00 A61P35/00 

Abstract RU 2779844 C2

FIELD: cell biology; medicine.

SUBSTANCE: present invention relates to the field of cell biology and medicine and discloses methods for the production of an isolated population of cells not inducing a reaction of “a graft vs host disease” (hereinafter – GvHD), having a phenotype of central memory T-lymphocytes (hereinafter – Tcm), as well as a population produced by such methods, and a method for the treatment of a subject who needs the transplantation of cells or tissues. To implement the specified methods for the production of a population, first, a population of T-cells is provided, containing at least 50% of memory T-cells. Then, the specified population is brought into contact with a viral, bacterial and/or tumor antigen in the presence of IL-21 in order to provide its enrichment with antigen-reactive cells. After that, the specified cells obtained above are cultivated in the presence of IL-21, IL-15 and/or IL-7 in order to provide proliferation of cells having Tcm phenotype.

EFFECT: present invention allows for the reproduction of functional antigen-reactive cells capable of providing effective and specific anti-diseases impact in order to eliminate host-reactive clones capable of causing GvHD.

24 cl, 26 dwg, 2 tbl, 6 ex

Similar patents RU2779844C2

Title Year Author Number
ANTI THIRD PARTY CENTRAL MEMORY T CELLS, METHODS FOR PRODUCTION THEREOF AND USE THEREOF IN TRANSPLANTATION AND DISEASE TREATMENT 2009
  • Rejzner Jajr
  • Ofir Eran
  • Ehjdelshtejn Jaki
  • Bachar-Lustig Ehster
RU2506311C2
CENTRAL MEMORY T-CELLS OF AGAINST THIRD PARTY, METHODS FOR THEIR PRODUCTION AND THEIR APPLICATION IN TRANSPLANTATION AND DISEASES TREATMENT 2012
  • Reisner Yair
  • Eidelatein Yaki
  • Ophir Eran
  • Lask Assaf
  • Afik Ran
  • Or-Geva Noga
  • Bachar-Lustig Esther
RU2636503C2
METHOD AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY 2012
  • Riddell Stenli R.
  • Khudetsek Mikhael
RU2688185C2
METHODS OF EXPANSION OF ANTIGEN-SPECIFIC CAR-T-CELLS, COMPOSITIONS AND THEIR USE 2019
  • Aftab, Blake, T.
  • Pham, Christina
  • Shen, Rhine
  • Wu, Michelle
RU2800920C2
NEW SUBPOPULATION OF TREG CD8CD45RC CELLS AND ITS APPLICATIONS 2016
  • Gilonno Karol
  • Anegon Ignasio
  • Bezi Severin
RU2766691C2
METHODS AND COMPOSITIONS FOR OBTAINING GENETICALLY ENGINEERED CELLS 2018
  • Bonyhadi, Mark L.
RU2795454C2
UNIVERSAL ANTIGEN PRESENTING CELLS AND THEIR USE 2019
  • Ang, Sonny, O.T.
  • Liu, Enli
  • Rezvani, Katy
  • Shpall, Elizabeth, J.
RU2809113C2
COMBINATION THERAPY FOR STABLE AND LONG TERM ENGRAFTMENT USING SPECIFIC PROTOCOLS FOR T/B-CELL DEPLETION 2012
  • Reisner Yair
  • Bachar-Lustig Esther
RU2648354C2
EXPANSION OF LYMPHOCYTE WITH A CYTOKINE COMPOSITION FOR ACTIVE CELLULAR IMMUNOTHERAPY 2015
  • Mojrer Markus
RU2739770C2
PRODUCTS OF A CERTAIN COMPOSITION CONTAINING GENETICALLY MODIFIED T CELLS 2015
  • Dzhensen Majkl K.
RU2751921C2

RU 2 779 844 C2

Authors

Reisner, Yair

Or-Geva, Noga

Gidron Budovsky, Rotem

Bachar-Lustig, Esther

Lask, Assaf

Kagan, Sivan

Dates

2022-09-14Published

2017-06-27Filed